MiRxes: David Capes
MiRxes, a developer of RNA-based test for early disease detection, has appointed David Capes as senior vice president and global head of innovation. Capes most recently served as VP of R&D for Greater Asia at Becton Dickinson. Prior to this, he held senior management roles at Pathway Biomed and Rockeby Biomed. He holds a PhD in pharmacy from Curtin University.